Cotrimoxazole Prophylaxis in Transurethral Resection or Greenlight Laser Vaporisation of the Prostate

PHASE4CompletedINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Antimicrobial Prophylaxis in Prostate Surgery
Interventions
DRUG

oral applications of TMP/SMX 800/160 mg (Nopil forte® tablets)

"five oral applications of TMP/SMX 800/160 mg (Nopil forte® tablets) at the evening of the surgery and thereafter twice daily on day~1 and 2 after surgery while the patient is in hospital."

DRUG

oral applications of Placebo

five oral applications of Placebo at the evening of the surgery and thereafter twice daily on day 1 and 2 after surgery while the patient is in hospital.

Trial Locations (5)

4031

University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology, Basel

4058

St. Claraspital, Department of Urology, Basel

4410

Kantonsspital Baselland, Department of Urology, Liestal

5001

Kantonsspital Aarau, Department of Urology, Aarau

8091

University Hospital Zurich, Department of Urology, Zurich

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT03633643 - Cotrimoxazole Prophylaxis in Transurethral Resection or Greenlight Laser Vaporisation of the Prostate | Biotech Hunter | Biotech Hunter